طباعة نهج Mayo ClinicPeople with advanced prostate cancer receive care from doctors at Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center is the only National Cancer Institute-designated comprehensive cancer center with three locations in Arizona, Florida and Minnesota. At Mayo Clinic, doctors and specialists work in multidisciplinary teams to address all your needs and explore all your options. Benefits of the team approach include: Expertise across all disciplines. Mayo Clinic doctors are highly skilled in all aspects of prostate cancer care and across every specialty involved in treating the condition. Collaboration. Mayo Clinic urologists, medical oncologists, radiation oncologists, nuclear medicine specialists, pathologists and radiologists rely on strong collaboration and multidisciplinary discussion to provide comprehensive care to each person with prostate cancer. Advanced diagnosis and treatmentMayo Clinic specialists have access to the latest diagnosis and treatment innovations to provide you with an accurate diagnosis and effective treatment plan. This includes: Detecting cancer recurrence sooner. Mayo Clinic was the first medical center to receive U.S. Food and Drug Administration approval to prepare and administer the choline C-11 PET scan, which helped doctors find prostate cancer recurrence sooner than other imaging available at the time. This innovation in prostate cancer imaging continues, as Mayo Clinic offers the latest tests, such as the PSMA PET scan. A full range of treatments to consider. Mayo Clinic doctors work with you to review all your treatment options and choose the treatment that suits your needs and goals. The range of treatments offered includes external beam radiation therapy, stereotactic body radiotherapy (SBRT), proton therapy, hormone therapy, targeted therapy, immunotherapy and radiopharmaceutical treatments. Access to the latest in clinical trials. Mayo Clinic doctors participate in clinical trials studying the latest treatments and new ways to use existing treatments. Taking part in a clinical trial may give you access to new medicines for metastatic castration-resistant prostate cancer (mCRPC). Talk with your healthcare team about which trials might be a good fit for you. الخبرة و مراتب التصنيفMayo Clinic doctors are widely respected for their experience and expertise in caring for people with prostate cancer. When you seek care at Mayo Clinic, you can expect: Experience you can trust. Each year, more than 23,000 people with prostate cancer receive care at Mayo Clinic. This experience means your care team is prepared with knowledge and resources to provide you with exactly the care you need. Center of excellence for radiopharmaceutical treatments. The Society of Nuclear Medicine and Molecular Imaging has designated Mayo Clinic as a Comprehensive Radiopharmaceutical Therapy Center of Excellence. This honor extends to the Mayo Clinic campuses in Arizona, Florida and Minnesota. Nationally recognized expertise. Mayo Clinic Comprehensive Cancer Center meets the strict standards for a National Cancer Institute-designated comprehensive cancer center. These standards recognize scientific excellence and a multispecialty approach focused on cancer prevention, diagnosis and treatment. Mayo Clinic Comprehensive Cancer Center is the only National Cancer Institute-designated comprehensive cancer center with three locations in Arizona, Florida and Minnesota. صنَّفت شبكة U.S. News & World Report مستشفى مايو كلينك في مدينة روتشستر بولاية مينيسوتا ومايو كلينك في مدينة جاكسونفيل بولاية فلوريدا ومايو كلينك في مدينتَي فينيكس وسكوتسديل بولاية أريزونا ضمن أفضل المستشفيات لعلاج السرطان. كما صُنف مستشفى مايو كلينك في مدينة روتشستر بولاية مينيسوتا كأفضل مستشفى في ولاية مينيسوتا، ومستشفى مايو كلينك في مدينتَي فينيكس وسكوتسديل بولاية أريزونا كأفضل مستشفى في ولاية أريزونا. مقر مايو كلينك في ولاية أريزونا مقر مايو كلينك في ولاية فلوريدا مقر مايو كلينك في ولاية مينيسوتا نظام مايو كلينك الصحي مؤسسة مايو كلينك للرعاية الصحية، في لندن المزيد من المعلومات عن الفواتير والتأمين: مجمعات مايو كلينيك في ولايات أريزونا وفلوريدا ومينيسوتا نظام مايو كلينك الصحي طلب تحديد موعد الأطباء والأقسام 28/01/2026 طباعةإظهار المَراجع Prostate cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1459. Accessed Dec. 10, 2025. Prostate cancer treatment (PDQ) – Health professional version. https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq. Accessed Dec. 10, 2025. Partin AW, et al., eds. Prostate cancer. In: Campbell Walsh Wein Handbook of Urology. Elsevier; 2022. https://www.clinicalkey.com. Accessed Dec. 10, 2025. Treating prostate cancer. American Cancer Society. https://www.cancer.org/cancer/types/prostate-cancer/treating.html. Accessed Dec. 10, 2025. Garje R, et al. Systemic therapy in patients with metastatic castration-resistant prostate cancer: ASCO guideline update. Journal of Clinical Oncology. 2025; doi:10.1200/JCO-25-00007. Hussain A, et al. Chemotherapy in advanced castration-resistant prostate cancer. https://www.uptodate.com/contents/search. Accessed Dec. 10, 2025. Dmochowski RR, et al., eds. Campbell-Walsh-Wein Urology. 13th ed. Elsevier; 2026. https://www.clinicalkey.com. Accessed Dec. 10, 2025. Chemotherapy. American Cancer Society. https://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy.html. Accessed Dec. 10, 2025. Medical review (expert opinion). Mayo Clinic. Dec. 2, 2025. Choline C 11 injection (approval letter). New Drug Application 203155. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155. Accessed April 4, 2025. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024. Become a comprehensive radiopharmaceutical therapy center of excellence. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Web/Clinical-Practice/Radiopharmaceutical-Therapy-Centers-of-Excellence/Become-a-Comprehensive-Radiopharmaceutical-Therapy-Center-of-Excellence.aspx. Accessed July 29, 2025. Tai HY, et al. Efficacy of cryotherapy in the prevention of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Supportive Care in Cancer. 2024; doi:10.1007/s00520-024-08680-3. ذات صلة تكرار الإصابة بسرطان البروستاتا سرطان البروستاتا سرطان البروستاتا النقيلي (المرحلة الرابعة) Chemotherapy for prostate cancerنبذةالأطباءوالأقسامالرعاية فيMayoClinic PRC-20592988 الاختبارات والإجراءات Chemotherapy for prostate cancer